Dane K Wukich1,2, Kimberlee B Hobizal3, Tresa L Sambenedetto4,2, Kristin Kirby3, Bedda L Rosario5. 1. Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA wukichdk@upmc.edu. 2. UPMC Mercy Amputation Prevention Center, Pittsburgh, PA, USA. 3. Heritage Valley Health Systems, Beaver, PA, USA. 4. Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 5. University of Pittsburgh Graduate School of Public Health, Department of Epidemiology, Pittsburgh, PA, USA.
Abstract
BACKGROUND: This study was conducted to evaluate the outcomes of patients with diabetic foot osteomyelitis (DFO) compared to diabetic foot soft tissue infections (STIs). METHODS: 229 patients who were hospitalized with foot infections were retrospectively reviewed, identifying 155 patients with DFO and 74 patients with STI. Primary outcomes evaluated were the rates of amputations and length of hospital stay. DFO was confirmed by the presence of positive bone culture and/or histopathology. RESULTS: Patients with DFO had a 5.6 times higher likelihood of overall amputation (P < .0001), a 3.4 times higher likelihood of major amputation (P = .027) and a 4.2 times higher likelihood of minor amputation (P < .0001) compared to patients without DFO. Major amputation was performed in 16.7% patients diagnosed with DFO and 5.3% of patients diagnosed with STI. Patients with DFO complicated by Charcot neuroarthropathy had a 7 times higher likelihood of undergoing major amputation (odds ratio 6.78, 95% confidence interval 2.70-17.01, P < .0001). The mean hospital stay was 7 days in DFO and 6 days in patients with DFI (P = .0082). Patients with DFO had a higher erythrocyte sedimentation rate (85 vs 71, P = .02) than patients with STI, however the differences in C-reactive protein (13.4 vs 11.8, P = .29) were not significantly different. CONCLUSION: In this study of moderate and severe DFIs, the presence of osteomyelitis resulted in a higher likelihood of amputation and longer hospital stay. Readers should recognize that the findings of this study may not be applicable to less severe cases of DFO that can be effectively managed in an outpatient setting. LEVEL OF EVIDENCE: Level III, retrospective comparative case series.
BACKGROUND: This study was conducted to evaluate the outcomes of patients with diabetic foot osteomyelitis (DFO) compared to diabetic foot soft tissue infections (STIs). METHODS: 229 patients who were hospitalized with foot infections were retrospectively reviewed, identifying 155 patients with DFO and 74 patients with STI. Primary outcomes evaluated were the rates of amputations and length of hospital stay. DFO was confirmed by the presence of positive bone culture and/or histopathology. RESULTS:Patients with DFO had a 5.6 times higher likelihood of overall amputation (P < .0001), a 3.4 times higher likelihood of major amputation (P = .027) and a 4.2 times higher likelihood of minor amputation (P < .0001) compared to patients without DFO. Major amputation was performed in 16.7% patients diagnosed with DFO and 5.3% of patients diagnosed with STI. Patients with DFO complicated by Charcot neuroarthropathy had a 7 times higher likelihood of undergoing major amputation (odds ratio 6.78, 95% confidence interval 2.70-17.01, P < .0001). The mean hospital stay was 7 days in DFO and 6 days in patients with DFI (P = .0082). Patients with DFO had a higher erythrocyte sedimentation rate (85 vs 71, P = .02) than patients with STI, however the differences in C-reactive protein (13.4 vs 11.8, P = .29) were not significantly different. CONCLUSION: In this study of moderate and severe DFIs, the presence of osteomyelitis resulted in a higher likelihood of amputation and longer hospital stay. Readers should recognize that the findings of this study may not be applicable to less severe cases of DFO that can be effectively managed in an outpatient setting. LEVEL OF EVIDENCE: Level III, retrospective comparative case series.
Authors: Todd J Kowalski; Miki Matsuda; Matthew D Sorenson; Jacob D Gundrum; William A Agger Journal: J Foot Ankle Surg Date: 2011 Mar-Apr Impact factor: 1.286
Authors: Francisco J Álvaro-Afonso; Jose L Lázaro-Martínez; Javier Aragón-Sánchez; Esther García-Morales; Almudena Cecilia-Matilla; Juan V Beneit-Montesinos Journal: Int J Low Extrem Wounds Date: 2013-02-01 Impact factor: 2.057
Authors: A R Berendt; E J G Peters; K Bakker; J M Embil; M Eneroth; R J Hinchliffe; W J Jeffcoate; B A Lipsky; E Senneville; J Teh; G D Valk Journal: Diabetes Metab Res Rev Date: 2008 May-Jun Impact factor: 4.876
Authors: E J Peters; B A Lipsky; J Aragón-Sánchez; E J Boyko; M Diggle; J M Embil; S Kono; L A Lavery; E Senneville; V Urbančič-Rovan; S A Van Asten; W J Jeffcoate Journal: Diabetes Metab Res Rev Date: 2016-01 Impact factor: 4.876
Authors: Lawrence A Lavery; Junho Ahn; Easton C Ryan; Kavita Bhavan; Orhan K Oz; Javier La Fontaine; Dane K Wukich Journal: Clin Orthop Relat Res Date: 2019-07 Impact factor: 4.176
Authors: Xiaoyan Jiang; Ning Li; Yi Yuan; Cheng Yang; Yan Chen; Yu Ma; Jianbai Wang; Dingyuan Du; Johnson Boey; David G Armstrong; Wuquan Deng Journal: Diabetes Metab Syndr Obes Date: 2020-06-30 Impact factor: 3.168
Authors: Kathryn E Davis; Javier La Fontaine; David Farrar; Orhan K Oz; Peter A Crisologo; Sandra Berriman; Lawrence A Lavery Journal: Wound Repair Regen Date: 2019-06-27 Impact factor: 3.617